Author: Carol Wang, Ph.D., Director of Clinical Research, We Are Here Clinical trials are crucial for many patients, by providing access to cutting-edge treatments and playing an important role in advancing medicine. However, many patients – especially those from underserved communities- face obstacles that limit their ability to participate. Common barriers include logistical challenges, financial concerns, and a lack of information …
Author: Carol Wang, Ph.D., Director of Clinical Research, We Are Here Cancer patients face significant financial challenges, especially when participating in clinical trials. Financial toxicity, the economic burden caused by cancer treatment costs, impacts patients’ ability to engage in trials that offer cutting-edge therapies. Despite the promise clinical trials hold for advancing cancer care, financial barriers—such as out-of-pocket costs, employment disruptions, …
Author: Carol Wang, Ph.D., Director of Clinical Research, We Are Here Financial toxicity, defined as the economic burden associated with cancer care, significantly affects cancer patients and their families. This impact extends beyond the immediate direct costs of treatment, affecting all aspects of a patient’s and their family’s lives, including indirect costs like lost income, employment stability, travel expenses, and …
